Vanguards of Health Care by Bloomberg Intelligence

IRhythm Technologies’ Zio ambulatory cardiac monitors have the potential to change how doctors screen for irregular heartbeats by combining miniaturized biosensors and AI data analytics into a patch, CEO Quentin Blackford explains to Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, Blackford sits down with BI analyst Matt Henriksson for an in-depth interview on iRhythm, how its Zio platform technology, powered by its second-generation AI network, allows patients to be monitored without disrupting their everyday lives and how the recent Camelot trial data shows Zio to be more accurate and less costly to the health-care system than traditional monitors.See omnystudio.com/listener for privacy information.

Caira Surgical is innovating radar technology to make it precise enough for use in navigating surgeons through knee-replacement procedures, where every millimeter matters for an accurate outcome, co-founders Jon Greenwald and Mort Meftah explain to Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, Greenwald and Meftah sit down with BI analyst Matt Henriksson for an in-depth interview about Caira, how sub-millimeter radar technology can be an improvement over traditional optical tracking for orthopedic surgery and the potential path to expand navigation and robotic capabilities within ambulatory surgical centers.See omnystudio.com/listener for privacy information.

Insulet is disrupting how patients can treat their diabetes, capitalizing on its differentiated Omnipod on-the-body delivery technology, CEO Jim Hollingshead explains to Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, Hollingshead sits down with BI analyst Matt Henriksson for an in-depth interview on Insulet’s Omnipod patch pump technology, how on-the-body wear compares with traditional insulin pumps and opens access to patients still using syringes, and upcoming developments to expand its automated insulin-delivery technology to Type 2 diabetic patients.See omnystudio.com/listener for privacy information.

Johnson & Johnson has multiple robotic development projects that are set to expand its market-leading position in advanced surgical technology, Hani Abouhalka, company group chairman, Robotics & Digital, Johnson & Johnson Medtech, explains to Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, Abouhalka sits down with BI analyst Matt Henriksson to talk about developments in J&J’s multiple robotic platforms, including the Monarch system for bronchoscopy and urological procedures and the Ottava system designed for general surgery; and how J&J’s Ethicon presence helps drive a differentiated experience for surgeons.See omnystudio.com/listener for privacy information.

Stereotaxis is developing robotic capabilities to enhance procedures for treating atrial fibrillation, with several innovations in the works. In this Vanguards of Health Care podcast episode, CEO David Fischel sits down with Bloomberg Intelligence analyst Matt Henriksson for a discussion about how the company’s Robotic Navigation System helps patients and future prospects for the use of robotics in cardiology surgery. See omnystudio.com/listener for privacy information.

Amputation is never a desired outcome. That’s why Podimetrics is working on innovations, as well as public awareness, around early detection of diabetic ulcers to prevent unnecessary procedures, co-founder and CEO Jon Bloom explains to Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, Jon sits down with BI analyst Matt Henriksson for an in-depth interview about Podimetrics, the state of diabetic ulcers and why current guidelines may be waiting until it is too late for patients with diabetic foot complications. He also reflects on how his experience as an anesthesiologist paved the way to develop the SmartMat as an in-home touchpoint for these patients.See omnystudio.com/listener for privacy information.

"This decade will be defined by the affordability crisis and our vision as a company is to solve the affordability crisis in US healthcare," apree health CEO Donald Trigg explains to Bloomberg Intelligence in this episode of the Vanguards of Health Care podcast. Trigg joins BI senior health care analyst Jonathan Palmer for a deep dive into apree's advanced primary care and digital engagement capabilities, how the combination of Vera Whole Health and Castlight positions the company to bring a differentiated solution set to help employers as well as health plans improve outcomes while lowering costs, and its progress in proving out its thesis across distinct market models.   See omnystudio.com/listener for privacy information.

Eddii is driving its diabetes-management technology around the concept that patients require emotional support as much as a glucose reading, cofounder Farhaneh Ahmadi explains to Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, Farhaneh sits down with BI analyst Matt Henriksson for an in-depth interview about the company, its diabetes-management app and its partnership with Dexcom that provides further benefit with continuous glucose monitors. Eddii’s initial launch in middle America, where some patients are hundreds of miles away from the nearest endocrinologist, is also discussed.See omnystudio.com/listener for privacy information.

“It was pretty clear as we looked at pharmacy-cost trends that where we were and where we were trying to go was just unsustainable,” Paul Markovich, CEO of Blue Shield of California explains to Bloomberg Intelligence. Markovich joins BI analyst Jonathan Palmer on this Vanguards of Health Care podcast episode to discuss the details of the company’s new prescription model, why it’s walking away from traditional pharmacy-benefit managers arrangements and how the insurer is going to generate $500 million in savings on over $4 billion in annual drug spending. Blue Shield’s work-around digital innovation, value-based care and the potential of GLP-1 drugs are also highlighted.See omnystudio.com/listener for privacy information.

"We're the only ones in navigation that engage directly with all providers to use health signals from both members and providers to create next best steps," Quantum Health's CEO Zane Burke explains to Bloomberg Intelligence. In this episode of the Vanguards of Health Care podcast, Burke joins BI analyst Jonathan Palmer to discuss the burgeoning need for health-care navigation and advocacy in a deep dive on Quantum's capabilities and how they improve clinical outcomes while generating a positive return on investment for clients. He also touches on a recent benefits survey that showed 60% of consultants recommend navigation for their clients and how Quantum's member engagement figures were the catalyst for joining the company. See omnystudio.com/listener for privacy information.